-
Purposeluciferase reporter for in vivo bioluminescence imaging
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 55764 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepGL4.17[luc2/Neo]
-
Backbone manufacturerPromega
- Backbone size w/o insert (bp) 5599
- Total vector size (bp) 7323
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameCMV enhancer/chicken beta actin promoter
-
Insert Size (bp)1732
- Promoter CMV enhancer/chicken beta actin promoter
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site SalI (destroyed during cloning)
- 3′ cloning site EcoRV (not destroyed)
- 5′ sequencing primer RV3 primer
- 3′ sequencing primer pCAG-F (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byThe SalI/EcoRV restriction fragment containing the CMV enhancer/chicken beta actin promoter was cut out of the pCAGEN plasmid (Addgene 11160)
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCAG-luciferase was a gift from Snorri Thorgeirsson (Addgene plasmid # 55764 ; http://n2t.net/addgene:55764 ; RRID:Addgene_55764) -
For your References section:
Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma. Lee YH, Andersen JB, Song HT, Judge AD, Seo D, Ishikawa T, Marquardt JU, Kitade M, Durkin ME, Raggi C, Woo HG, Conner EA, Avital I, Maclachlan I, Factor VM, Thorgeirsson SS. Cancer Res. 2010 Nov 1;70(21):8264-9. doi: 10.1158/0008-5472.CAN-10-0749. Epub 2010 Oct 19. 10.1158/0008-5472.CAN-10-0749 PubMed 20959491